EUGENEX Biotechnologies

EUGENEX Biotechnologies is a privately owned and independent research and service company founded in 1998 by Michael O. Zang-Gandor and Dr. Christine Gandor. The company specializes in innovative technologies for producing heterologous proteins and conducting cellular assays. It operates state-of-the-art laboratories in the Spidertown Technology Development Center in Taegerwilen, TG, Switzerland, about 45 minutes from Zurich Airport.

The company's proprietary GeneXpress system provides ready-to-go cell lines and complete or partial processes for commercial manufacturing of biosimilars and novel biopharmaceuticals. Their technology platform relies on reliable CHOSI host cell lines, protein-free MAM-PF cell culture media, and high-level pMOZ expression plasmids to deliver excellent yields with high product quality.

EUGENEX offers a wide range of in-house services related to preclinical development that are available on a modular basis. These services include cell line and process development, gram-scale protein production and purification (non-GMP), analytical and cell-based assays, and technology transfer and training, all fully customizable to client needs.

The company currently runs 700 square meters of laboratories and employs 12 highly skilled people. Their product portfolio includes more than 45 biopharmaceuticals across different therapeutic areas, with over 12 biosimilars already reaching regulated and non-regulated markets.

EUGENEX Biotechnologies is located at Konstanzerstrasse 19 in CH-8274 Tägerwilen, Switzerland. Clients can reach the office at +41 (0) 71 666 43 60 or the lab at +41 (0) 71 666 43 61, and send inquiries to [email protected].

The company aims to simplify FDA or EMA approval through its expertise in regulatory issues and biosafety. Their products are designed for animal component-free (ACF) production of biosimilars and novel biopharmaceuticals, ensuring they meet the steadily increasing demands of regulatory bodies.

Reviewers consistently praise the exceptional quality of the biotech products and the high-level professionalism of the team. Many customers highlight the helpfulness and responsiveness of the customer service team, noting that they are always available to answer questions or concerns.

Some reviewers mention that the pricing is very competitive and the quality is top-notch. Others note that the products have been instrumental in their research, making a significant difference in their work.

The Trustburn listing shows a 4 out of 5 rating from 9 reviews, with the most recent feedback dating back to November 2023. The reviews are overwhelmingly positive, with only one review scoring a 3 out of 5, while the majority are 4 or 5 stars.

Scale-up of processes can be performed in up to 200 L scale disposable and 350 L scale stainless steel bioreactors. The company also offers technology transfer that includes the transfer of SOPs and protocols, cell handling training, and process performance.

The company envisions a world committed to sustainable global healthcare and works to realize this vision with quality, cost-saving production systems. They aim to improve people's lives and make life-saving medicine accessible to everyone through their innovative approach.

EUGENEX engages in the co-development of new pharmaceutical drugs in addition to biosimilar development and contract production. They also conduct their own research activities to advance biotechnology and provide tailored solutions for clients' specific needs.

The company provides services for the production of heterologous proteins and cellular assays, targeting R&D and the Pharma/Biotech-Industry. They offer everything from gene to product, including ready-to-go biosimilar processes and complete manufacturing processes.

The official website of EUGENEX Biotechnologies is eugenex.com.